1. Home
  2. LSTA vs ATER Comparison

LSTA vs ATER Comparison

Compare LSTA & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • ATER
  • Stock Information
  • Founded
  • LSTA 1980
  • ATER 2014
  • Country
  • LSTA United States
  • ATER United States
  • Employees
  • LSTA N/A
  • ATER N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • ATER Home Furnishings
  • Sector
  • LSTA Health Care
  • ATER Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • ATER Nasdaq
  • Market Cap
  • LSTA 20.0M
  • ATER 19.5M
  • IPO Year
  • LSTA N/A
  • ATER N/A
  • Fundamental
  • Price
  • LSTA $2.07
  • ATER $2.14
  • Analyst Decision
  • LSTA Strong Buy
  • ATER Strong Buy
  • Analyst Count
  • LSTA 1
  • ATER 1
  • Target Price
  • LSTA $15.00
  • ATER N/A
  • AVG Volume (30 Days)
  • LSTA 9.1K
  • ATER 2.8M
  • Earning Date
  • LSTA 05-08-2025
  • ATER 05-06-2025
  • Dividend Yield
  • LSTA N/A
  • ATER N/A
  • EPS Growth
  • LSTA N/A
  • ATER N/A
  • EPS
  • LSTA N/A
  • ATER N/A
  • Revenue
  • LSTA $1,000,000.00
  • ATER $99,045,000.00
  • Revenue This Year
  • LSTA N/A
  • ATER $5.62
  • Revenue Next Year
  • LSTA N/A
  • ATER $8.63
  • P/E Ratio
  • LSTA N/A
  • ATER N/A
  • Revenue Growth
  • LSTA N/A
  • ATER N/A
  • 52 Week Low
  • LSTA $2.05
  • ATER $1.86
  • 52 Week High
  • LSTA $4.20
  • ATER $3.95
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 34.86
  • ATER 47.50
  • Support Level
  • LSTA $2.31
  • ATER $2.09
  • Resistance Level
  • LSTA $2.46
  • ATER $2.56
  • Average True Range (ATR)
  • LSTA 0.15
  • ATER 0.29
  • MACD
  • LSTA -0.01
  • ATER -0.02
  • Stochastic Oscillator
  • LSTA 0.00
  • ATER 5.56

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: